BIO-TECHNE CORP (TECH) Stock Analyst Ratings
USA - NASDAQ:TECH - US09073M1045 - Common Stock
65.905 USD
-0.16 (-0.23%)
65.905 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to TECH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 66.98. This target is 1.63% above the current price.
TECH was analyzed by 23 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about TECH.
In the previous month the buy percentage consensus was at a similar level.
TECH was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-14 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-03 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2025-08-21 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-07-11 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-07-09 | TD Cowen | Initiate | Buy |
| 2025-06-05 | Benchmark | Reiterate | Buy -> Buy |
| 2025-05-30 | Wells Fargo | Initiate | Overweight |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-05-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-08 | Benchmark | Maintains | Buy -> Buy |
| 2025-05-08 | Stifel | Maintains | Hold -> Hold |
| 2025-04-09 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-04-08 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-03-18 | Evercore ISI Group | Initiate | Outperform |
| 2025-03-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-02-19 | Baird | Downgrade | Outperform -> Neutral |
| 2025-02-06 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-06 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-02-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-10-31 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-10-31 | Baird | Maintains | Outperform -> Outperform |
| 2024-08-13 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-05-22 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-05-02 | Benchmark | Reiterate | Buy -> Buy |
| 2024-05-02 | Baird | Maintains | Outperform -> Outperform |
| 2024-04-18 | Deutsche Bank | Maintains | Buy -> Buy |
BIO-TECHNE CORP / TECH FAQ
What do analysts expect the price target to be for BIO-TECHNE CORP (TECH)?
23 analysts have analysed TECH and the average price target is 66.98 USD. This implies a price increase of 1.63% is expected in the next year compared to the current price of 65.905.
Can you provide the consensus rating for BIO-TECHNE CORP stock?
The consensus rating for BIO-TECHNE CORP (TECH) is 81.7391 / 100 . This indicates that analysts generally have a positive outlook on the stock.